We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+11.38%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$225M
AUM Growth
+$16.4M
Cap. Flow
-$3.11M
Cap. Flow %
-1.38%
Top 10 Hldgs %
37.76%
Holding
984
New
21
Increased
118
Reduced
237
Closed
53

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$817K
2
NVDA icon
NVIDIA
NVDA
+$217K
3
MRSH
Marsh
MRSH
+$145K
4
FTNT icon
Fortinet
FTNT
+$143K
5
AVGO icon
Broadcom
AVGO
+$143K

Sector Composition

Rank Sector Weight
1 Technology 41.58%
2 Healthcare 11.76%
3 Financials 6.86%
4 Consumer Staples 6.86%
5 Consumer Discretionary 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EOG icon
826
EOG Resources
EOG
$77.5B
-100
Closed -$11K
FANG icon
827
Diamondback Energy
FANG
$57.8B
-20
Closed -$3K
FG icon
828
F&G Annuities & Life
FG
$3.86B
-2
Closed
FIBK icon
829
First Interstate BancSystem
FIBK
$3.7B
$0 ﹤0.01%
20
FNF icon
830
Fidelity National Financial
FNF
$13.1B
-31
Closed -$1K
GAIA icon
831
Gaia
GAIA
$47.1M
$0 ﹤0.01%
20
GLPI icon
832
Gaming and Leisure Properties
GLPI
$12.6B
-45
Closed -$2K
GTBP icon
833
GT Biopharma
GTBP
$12.1M
$0 ﹤0.01%
2
GTX icon
834
Garrett Motion
GTX
$5.9B
$0 ﹤0.01%
10
HSDT icon
835
Solana Company
HSDT
$99.3M
0
HUN icon
836
Huntsman Corp
HUN
$2.25B
-77
Closed -$2K
IIPR icon
837
Innovative Industrial Properties
IIPR
$1.78B
$0 ﹤0.01%
3
INKT icon
838
MiNK Therapeutics
INKT
$51.6M
0
IWO icon
839
iShares Russell 2000 Growth ETF
IWO
$14.6B
-52
Closed -$12K
JACK icon
840
Jack in the Box
JACK
$263M
-11
Closed -$1K
LCID icon
841
Lucid Motors
LCID
$2.52B
-20
Closed -$2K
MAT icon
842
Mattel
MAT
$4.14B
-5
Closed
MBOT icon
843
Microbot Medical
MBOT
$118M
$0 ﹤0.01%
1
METV icon
844
Roundhill Ball Metaverse ETF
METV
$210M
-1,000
Closed -$9K
MLKN icon
845
MillerKnoll
MLKN
$1.46B
$0 ﹤0.01%
16
DFTX
846
Definium Therapeutics
DFTX
$5.7B
-133
Closed
NTLA icon
847
Intellia Therapeutics
NTLA
$1.55B
-100
Closed -$4K
NVAX icon
848
Novavax
NVAX
$1.29B
-200
Closed -$1K
ADAM
849
Adamas Trust
ADAM
$772M
$0 ﹤0.01%
29
OGN icon
850
Organon & Co
OGN
$3.56B
$0 ﹤0.01%
13

Similar funds

Front Row Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Front Row Advisors held 984 positions worth $225M, up 7.8% from $208M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Front Row Advisors's Q2 2023 filing shows 21 new, 118 increased, 237 reduced and 53 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 635 shares worth $31K. The largest sale was Medtronic, an estimated $817K.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 38% a quarter earlier, followed by Healthcare and Financials.

  • Front Row Advisors's largest Q2 2023 buy was JPMorgan Nasdaq Equity Premium Income ETF: 635 shares worth $31K.
  • Front Row Advisors added most to Invesco QQQ Trust in Q2 2023, an estimated $99K increase.
  • Front Row Advisors's biggest Q2 2023 reduction was Medtronic, cutting an estimated $817K.
  • Front Row Advisors fully exited ProShares UltraShort S&P500 in Q2 2023, selling an estimated $97K.
  • Front Row Advisors's ten largest holdings make up 38% of its $225M portfolio in Q2 2023.
  • Front Row Advisors opened 21 new positions and closed 53 in Q2 2023.
  • Front Row Advisors's portfolio value rose 7.8% quarter-over-quarter to $225M.

Based on Front Row Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.